Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.9M Sell
206,918
-41,357
-17% -$2.15M 0.17% 57
2026
Q1
$13M Sell
248,275
-26,725
-10% -$1.37M 0.22% 54
2025
Q4
$13.3M Hold
275,000
0.23% 51
2025
Q3
$13.2M Buy
+275,000
New +$13.4M 0.23% 49

Other funds holding UTL

W.H. Reaves & Co's UTL Position: Q2 2026 in Review

W.H. Reaves & Co reduced its Unitil (UTL) stake by 17% in Q2 2026, selling an estimated $2.15M and leaving 206,918 shares worth $10.9M. The position accounts for 0.17% of the portfolio, ranked #57.

W.H. Reaves & Co first reported a position in UTL in Q3 2025 and has held it in 4 quarters since. The position peaked at $13.3M in Q4 2025. 243 funds tracked by Wall St. Rank hold UTL as of Q2 2026.

  • W.H. Reaves & Co held 206,918 shares of Unitil worth $10.9M as of Q2 2026.
  • W.H. Reaves & Co sold 41,357 Unitil shares in Q2 2026, an estimated $2.15M.
  • Unitil made up 0.17% of W.H. Reaves & Co's portfolio in Q2 2026, its #57 holding.
  • W.H. Reaves & Co first reported a position in Unitil in Q3 2025 and has held it in 4 quarters since.
  • W.H. Reaves & Co's Unitil position peaked at $13.3M in Q4 2025.
  • 243 funds tracked by Wall St. Rank held Unitil as of Q2 2026.

Based on W.H. Reaves & Co's 13F filing for Q2 2026, filed 30 Jul 2026.